BRPI1011888A2 - processo para preparar um composto, e, composição. - Google Patents

processo para preparar um composto, e, composição.

Info

Publication number
BRPI1011888A2
BRPI1011888A2 BRPI1011888A BRPI1011888A BRPI1011888A2 BR PI1011888 A2 BRPI1011888 A2 BR PI1011888A2 BR PI1011888 A BRPI1011888 A BR PI1011888A BR PI1011888 A BRPI1011888 A BR PI1011888A BR PI1011888 A2 BRPI1011888 A2 BR PI1011888A2
Authority
BR
Brazil
Prior art keywords
preparing
compound
composition
Prior art date
Application number
BRPI1011888A
Other languages
English (en)
Inventor
Karl-Heinz Giselbrecht
Michael Wolberg
Ulfried Felfer
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of BRPI1011888A2 publication Critical patent/BRPI1011888A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BRPI1011888A 2009-07-02 2010-07-01 processo para preparar um composto, e, composição. BRPI1011888A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27007309P 2009-07-02 2009-07-02
PCT/US2010/040792 WO2011002999A1 (en) 2009-07-02 2010-07-01 Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt

Publications (1)

Publication Number Publication Date
BRPI1011888A2 true BRPI1011888A2 (pt) 2016-04-12

Family

ID=42937685

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1011888A BRPI1011888A2 (pt) 2009-07-02 2010-07-01 processo para preparar um composto, e, composição.

Country Status (21)

Country Link
US (3) US8299242B2 (pt)
EP (1) EP2448950B1 (pt)
JP (1) JP5739882B2 (pt)
CN (1) CN102482305B (pt)
AU (1) AU2010266213B2 (pt)
BR (1) BRPI1011888A2 (pt)
CA (1) CA2766801C (pt)
CY (1) CY1117489T1 (pt)
DK (1) DK2448950T3 (pt)
EA (1) EA021657B1 (pt)
ES (1) ES2565985T3 (pt)
HR (1) HRP20160319T1 (pt)
HU (1) HUE027212T2 (pt)
ME (1) ME02388B (pt)
PL (1) PL2448950T3 (pt)
RS (1) RS54679B1 (pt)
SG (1) SG176799A1 (pt)
SI (1) SI2448950T1 (pt)
SM (1) SMT201600084B (pt)
UA (1) UA108077C2 (pt)
WO (1) WO2011002999A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
AU2011218805A1 (en) * 2010-02-24 2012-08-30 Auspex Pharmaceuticals, Inc. Trimethoxyphenyl inhibitors of tyrosine kinase
SMT201900071T1 (it) 2011-07-28 2019-02-28 Rigel Pharmaceuticals Inc Nuove formulazioni di (trimetossifenilammino)pirimidinile
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
EP2861608B8 (en) 2012-06-19 2019-06-19 Debiopharm International SA Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
CN102746337B (zh) * 2012-06-21 2014-12-17 成都苑东药业有限公司 一种2,4-嘧啶二胺类化合物及其制备方法
US9145411B2 (en) 2012-08-02 2015-09-29 Asana Biosciences, Llc Substituted amino-pyrimidine derivatives
CA3186267C (en) 2013-12-20 2025-09-09 Rigel Pharmaceuticals, Inc. PHARMACEUTICAL PROCESS AND INTERMEDIARIES
DK3419628T3 (da) 2016-02-26 2021-01-11 Debiopharm Int Sa Medikament til behandling af diabetiske fodinfektioner
US20180065992A1 (en) 2016-09-08 2018-03-08 Glykon Technologies Group, Llc Monomeric bimetal hydroxycitric acid compounds and methods of making and using the same
EP3692041A1 (en) * 2017-10-04 2020-08-12 Celgene Corporation Processes for the preparation of cis-4 [2-{(3s.4r)-3-fluorooxan-4-yl]amino)-8-(2,4,6-trichloroanilino)-9h-purin-9-yl]-1-methylcyclohexane-1-carboxamide
ES2944535T3 (es) 2019-02-14 2023-06-22 Debiopharm Int Sa Formulación de afabicina, método para preparar la misma
UA129222C2 (uk) 2019-06-14 2025-02-12 Дебіофарм Інтернешнл С.А. Лікарський засіб і його застосування для лікування бактеріальних інфекцій, пов'язаних з біоплівкою

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US303022A (en) 1884-08-05 Egg-beater
US324087A (en) 1885-08-11 Abel combs
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
AU2003221887A1 (en) 2002-04-12 2003-10-27 Tritek Technologies, Inc. Mail sorting processes and systems
IL166241A0 (en) 2002-07-29 2006-01-15 Rigel Pharmaceuticals Inc Method of treating or preventing autoimmune diseases with 2,4-pyrimidinedinediamine compounds
ES2421139T3 (es) 2003-07-30 2013-08-29 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
US20060047135A1 (en) 2004-08-30 2006-03-02 Chadwick Scott T Process for preparing chloromethyl di-tert-butylphosphate
US7449458B2 (en) * 2005-01-19 2008-11-11 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
CN101282979B (zh) * 2005-09-13 2011-09-21 卫材R&D管理有限公司 稳定性被改善的含有磷酸氯甲酯衍生物的组合物及其制备方法
WO2008064274A1 (en) * 2006-11-21 2008-05-29 Rigel Pharmaceuticals, Inc. Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну

Also Published As

Publication number Publication date
HUE027212T2 (en) 2016-10-28
EA201270114A1 (ru) 2012-05-30
UA108077C2 (xx) 2015-03-25
US20110003986A1 (en) 2011-01-06
RS54679B1 (sr) 2016-08-31
HRP20160319T1 (hr) 2016-04-22
CA2766801A1 (en) 2011-01-06
CY1117489T1 (el) 2017-04-26
US8299242B2 (en) 2012-10-30
PL2448950T3 (pl) 2016-06-30
ES2565985T3 (es) 2016-04-08
US8481724B2 (en) 2013-07-09
JP2012532143A (ja) 2012-12-13
SG176799A1 (en) 2012-01-30
EP2448950A1 (en) 2012-05-09
CN102482305B (zh) 2016-07-13
SI2448950T1 (sl) 2016-05-31
AU2010266213A1 (en) 2012-02-02
US20130274499A1 (en) 2013-10-17
JP5739882B2 (ja) 2015-06-24
US20130018185A1 (en) 2013-01-17
DK2448950T3 (en) 2016-04-04
SMT201600084B (it) 2016-04-29
EA021657B1 (ru) 2015-08-31
WO2011002999A1 (en) 2011-01-06
CA2766801C (en) 2018-03-13
HK1169996A1 (zh) 2013-02-15
US8691798B2 (en) 2014-04-08
EP2448950B1 (en) 2016-01-13
AU2010266213B2 (en) 2015-06-18
ME02388B (me) 2016-09-20
CN102482305A (zh) 2012-05-30

Similar Documents

Publication Publication Date Title
BRPI1014547A2 (pt) composto, e, processo para preparar um composto.
BRPI0812054A2 (pt) Processo para preparar compostos, e, compostos.
BRPI0910910A2 (pt) processo para preparar um composto
BRPI0910911A2 (pt) processo para preparar um composto
BRPI0911898A2 (pt) processo para preparar compostos, e, composto.
BRPI0814980A2 (pt) Processo para produzir um composto, e, composto.
BRPI0909691A8 (pt) composto, método para preparar um composto, e, composição farmacêutica
BRPI0911531A2 (pt) processo para preparar iopromida, e, composto.
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BR112013008008A2 (pt) composto, composição farmacêutica e processo para preparar um composto
BRPI1012018A2 (pt) processo para preparar um composto
BRPI0914674A2 (pt) processo para preparação de um pó
BRPI0908252A2 (pt) Processo para preparar um composto, e, uso de um composto
BRPI1010933A2 (pt) processo para a preparação de um pó, e, composto
BRPI0921882A2 (pt) processo para fabricar um composto.
BRPI0909280A2 (pt) processo para preparar uretanos.
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
BR112012001462A2 (pt) processo para preparar metil mercaptano.
BRPI0813772A2 (pt) Composto, processo para a preparação de um composto, e, conjugado
BRPI1008987A2 (pt) processo para preparar 3,3,3-trifluoropropeno
BRPI1013561A8 (pt) processo para a preparação de alogliptina
BRPI1009816A2 (pt) "método para preparar um composto."
BRPI0914924A2 (pt) processo para preparar aminobifenilas, e, composto.
BRPI1016109A2 (pt) "composto, composição farmacêutica, e, processo para preparar um composto"
BR112012002130A2 (pt) processo para a preparação de composto,e, composto intermediário

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]